Narae Nanotech Corporation

KOSDAQ:A137080 Stock Report

Market Cap: ₩32.3b

Narae Nanotech Balance Sheet Health

Financial Health criteria checks 1/6

Narae Nanotech has a total shareholder equity of ₩84.8B and total debt of ₩65.8B, which brings its debt-to-equity ratio to 77.6%. Its total assets and total liabilities are ₩171.8B and ₩87.1B respectively.

Key information

77.6%

Debt to equity ratio

₩65.80b

Debt

Interest coverage ration/a
Cash₩4.68b
Equity₩84.79b
Total liabilities₩87.06b
Total assets₩171.85b

Recent financial health updates

Recent updates

Narae Nanotech Corporation (KOSDAQ:137080) May Have Run Too Fast Too Soon With Recent 25% Price Plummet

Nov 12
Narae Nanotech Corporation (KOSDAQ:137080) May Have Run Too Fast Too Soon With Recent 25% Price Plummet

Narae Nanotech (KOSDAQ:137080) Has Debt But No Earnings; Should You Worry?

Aug 09
Narae Nanotech (KOSDAQ:137080) Has Debt But No Earnings; Should You Worry?

Narae Nanotech (KOSDAQ:137080) Is Carrying A Fair Bit Of Debt

Mar 12
Narae Nanotech (KOSDAQ:137080) Is Carrying A Fair Bit Of Debt

Financial Position Analysis

Short Term Liabilities: A137080's short term assets (₩69.8B) do not cover its short term liabilities (₩73.7B).

Long Term Liabilities: A137080's short term assets (₩69.8B) exceed its long term liabilities (₩13.4B).


Debt to Equity History and Analysis

Debt Level: A137080's net debt to equity ratio (72.1%) is considered high.

Reducing Debt: Insufficient data to determine if A137080's debt to equity ratio has reduced over the past 5 years.

Debt Coverage: A137080's operating cash flow is negative, therefore debt is not well covered.

Interest Coverage: Insufficient data to determine if A137080's interest payments on its debt are well covered by EBIT.


Balance Sheet


Discover healthy companies